Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord
In recent years, gene therapy has been raising hopes toward viable treatment strategies for rare genetic diseases for which there has been almost exclusively supportive treatment. We here review this progress at the pre-clinical and clinical trial levels as well as market approvals within diseases t...
Main Authors: | Thomas Leth Jensen, Casper René Gøtzsche, David P. D. Woldbye |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2021.695937/full |
Similar Items
-
Sensory changes in pediatric patients with spinal muscular atrophy: an electrophysiologic study
by: Hussien E Sultan, et al.
Published: (2016-01-01) -
Neuroprotective effect of non-viral gene therapy treatment based on tetanus toxin C-fragment in a severe mouse model of Spinal Muscular Atrophy.
by: Sara Olivan Garcia, et al.
Published: (2016-08-01) -
Imaging of the Spinal Cord in Multiple Sclerosis: Past, Present, Future
by: Yongsheng Chen, et al.
Published: (2020-11-01) -
Pilot Study on Quantitative Cervical Cord and Muscular MRI in Spinal Muscular Atrophy: Promising Biomarkers of Disease Evolution and Treatment?
by: Giovanni Savini, et al.
Published: (2021-03-01) -
Biomarkers in Rare Disorders: The Experience with Spinal Muscular Atrophy
by: Christina Brahe, et al.
Published: (2010-12-01)